178 related articles for article (PubMed ID: 12527113)
21. Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration.
Wang AC; Jensen EH; Rexach JE; Vinters HV; Hsieh-Wilson LC
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15120-15125. PubMed ID: 27956640
[TBL] [Abstract][Full Text] [Related]
22. Localization and in situ phosphorylation state of nuclear tau.
Greenwood JA; Johnson GV
Exp Cell Res; 1995 Oct; 220(2):332-7. PubMed ID: 7556441
[TBL] [Abstract][Full Text] [Related]
23. O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers.
Yuzwa SA; Cheung AH; Okon M; McIntosh LP; Vocadlo DJ
J Mol Biol; 2014 Apr; 426(8):1736-52. PubMed ID: 24444746
[TBL] [Abstract][Full Text] [Related]
24. Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody.
Yuzwa SA; Yadav AK; Skorobogatko Y; Clark T; Vosseller K; Vocadlo DJ
Amino Acids; 2011 Mar; 40(3):857-68. PubMed ID: 20706749
[TBL] [Abstract][Full Text] [Related]
25. A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo.
Yuzwa SA; Macauley MS; Heinonen JE; Shan X; Dennis RJ; He Y; Whitworth GE; Stubbs KA; McEachern EJ; Davies GJ; Vocadlo DJ
Nat Chem Biol; 2008 Aug; 4(8):483-90. PubMed ID: 18587388
[TBL] [Abstract][Full Text] [Related]
26. Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration.
Yang CC; Kuai XX; Gao WB; Yu JC; Wang Q; Li L; Zhang L
J Alzheimers Dis; 2016; 51(1):33-44. PubMed ID: 26836014
[TBL] [Abstract][Full Text] [Related]
27. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
Vosseller K; Wells L; Lane MD; Hart GW
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
[TBL] [Abstract][Full Text] [Related]
28. Influence of serine O-glycosylation or O-phosphorylation close to the vJun nuclear localisation sequence on nuclear import.
Schlummer S; Vetter R; Kuder N; Henkel A; Chen YX; Li YM; Kuhlmann J; Waldmann H
Chembiochem; 2006 Jan; 7(1):88-97. PubMed ID: 16345111
[TBL] [Abstract][Full Text] [Related]
29. Catalytic Promiscuity of O-GlcNAc Transferase Enables Unexpected Metabolic Engineering of Cytoplasmic Proteins with 2-Azido-2-deoxy-glucose.
Shen DL; Liu TW; Zandberg W; Clark T; Eskandari R; Alteen MG; Tan HY; Zhu Y; Cecioni S; Vocadlo D
ACS Chem Biol; 2017 Jan; 12(1):206-213. PubMed ID: 27935279
[TBL] [Abstract][Full Text] [Related]
30. A local insult of okadaic acid in wild-type mice induces tau phosphorylation and protein aggregation in anatomically distinct brain regions.
Baker S; Götz J
Acta Neuropathol Commun; 2016 Mar; 4():32. PubMed ID: 27037086
[TBL] [Abstract][Full Text] [Related]
31. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.
Gatta E; Lefebvre T; Gaetani S; dos Santos M; Marrocco J; Mir AM; Cassano T; Maccari S; Nicoletti F; Mairesse J
Pharmacol Res; 2016 Mar; 105():186-97. PubMed ID: 26816085
[TBL] [Abstract][Full Text] [Related]
32. The new indirubin derivative inhibitors of glycogen synthase kinase-3, 6-BIDECO and 6-BIMYEO, prevent tau phosphorylation and apoptosis induced by the inhibition of protein phosphatase-2A by okadaic acid in cultured neurons.
Martin L; Magnaudeix A; Wilson CM; Yardin C; Terro F
J Neurosci Res; 2011 Nov; 89(11):1802-11. PubMed ID: 21826701
[TBL] [Abstract][Full Text] [Related]
33. Reversible in vivo phosphorylation of tau induced by okadaic acid and by unspecific brain lesion in rat.
Janke C; Gärtner U; Holzer M; Arendt T
J Hirnforsch; 1998; 39(2):143-53. PubMed ID: 10022338
[TBL] [Abstract][Full Text] [Related]
34. Okadaic acid-induced Tau phosphorylation in rat brain: role of NMDA receptor.
Kamat PK; Rai S; Swarnkar S; Shukla R; Ali S; Najmi AK; Nath C
Neuroscience; 2013 May; 238():97-113. PubMed ID: 23415789
[TBL] [Abstract][Full Text] [Related]
35. Translocation of HSP27 into liver cancer cell nucleus may be associated with phosphorylation and O-GlcNAc glycosylation.
Guo K; Gan L; Zhang S; Cui FJ; Cun W; Li Y; Kang NX; Gao MD; Liu KY
Oncol Rep; 2012 Aug; 28(2):494-500. PubMed ID: 22664592
[TBL] [Abstract][Full Text] [Related]
36. Intracellular glycosylation and development.
O'Donnell N
Biochim Biophys Acta; 2002 Dec; 1573(3):336-45. PubMed ID: 12417416
[TBL] [Abstract][Full Text] [Related]
37. Global Analysis of O-GlcNAc Glycoproteins in Activated Human T Cells.
Lund PJ; Elias JE; Davis MM
J Immunol; 2016 Oct; 197(8):3086-3098. PubMed ID: 27655845
[TBL] [Abstract][Full Text] [Related]
38. Induction of Alzheimer-specific Tau epitope AT100 in apoptotic human fetal astrocytes.
Ksiezak-Reding H; He D; Gordon-Krajcer W; Kress Y; Lee S; Dickson DW
Cell Motil Cytoskeleton; 2000 Nov; 47(3):236-52. PubMed ID: 11056524
[TBL] [Abstract][Full Text] [Related]
39. Both secreted and the cellular levels of BDNF attenuated due to tau hyperphosphorylation in primary cultures of cortical neurons.
Atasoy İL; Dursun E; Gezen-Ak D; Metin-Armağan D; Öztürk M; Yılmazer S
J Chem Neuroanat; 2017 Mar; 80():19-26. PubMed ID: 27914953
[TBL] [Abstract][Full Text] [Related]
40. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress.
Zachara NE; Hart GW
Biochim Biophys Acta; 2004 Jul; 1673(1-2):13-28. PubMed ID: 15238246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
